MAP2K7 and lung cancer: These observations are in line with previous studies demonstrating MEK inhibition sensitization of HDAC inhibitor-caused cell death in leukemia, breast, colon, and lung cancer cells through blockade of ERK signaling [17–19, 33, 34].